Hallux Rigidus

1. Clinical Overview

Summary

Hallux rigidus is degenerative osteoarthritis of the first metatarsophalangeal (MTP) joint, representing the most common arthritic condition affecting the foot with a prevalence of 2.5% in adults over 50 years. [1] Unlike hallux valgus (bunion deformity), hallux rigidus is characterized by progressive loss of dorsiflexion secondary to dorsal osteophyte formation and cartilage degeneration, resulting in a painful, stiff great toe that compromises normal gait mechanics. [2]

The pathognomonic feature is the formation of large dorsal osteophytes (bone spurs) on the metatarsal head that create a mechanical block to dorsiflexion, causing impingement pain during the terminal stance phase of gait (toe-off). [3] This "wear and tear" arthropathy progresses through well-defined radiographic and clinical stages, necessitating a stage-appropriate treatment algorithm.

Treatment follows a stepwise progression: early-stage disease (Grades 1-2) with preserved joint space responds well to cheilectomy (excision of dorsal osteophytes and 20-30% of the dorsal metatarsal head), while advanced disease (Grades 3-4) with severe joint destruction requires arthrodesis (fusion), which remains the gold standard definitive treatment with 90-95% patient satisfaction rates. [4,5]

Key Facts

• The "Dorsal Bunion": Patients frequently describe a "bunion on top of the toe"—this represents the dorsal osteophyte, not a true bunion deformity.
• Stiff vs Crooked: Hallux rigidus presents as a straight, stiff toe (loss of motion), whereas hallux valgus presents as a crooked, hypermobile toe (deformity). Severe coexistence is rare.
• The Fusion Misconception: Patients often express concern about post-fusion mobility. First MTP arthrodesis allows normal walking, jogging, and recreational activities. Limitations are confined to high-heeled footwear and elite-level sprinting. [6]
• Prevalence: Affects 1 in 40 adults over 50 years, with female predominance (F:M ratio 2:1). [1]
• Biomechanical Demand: The 1st MTP joint bears 40-60% of body weight during toe-off and requires 65-75° of dorsiflexion for normal gait. [7]

Clinical Pearls

"Check the ROM": In early-stage hallux rigidus (Grades 1-2), plantarflexion is typically preserved while dorsiflexion is selectively restricted by dorsal impingement. In late-stage disease (Grades 3-4), the joint becomes globally stiff with restriction in all planes.

"Carbon Plate Principle": A rigid carbon-fiber insole extension (Morton's extension orthotic) functions as an external splint, preventing 1st MTP dorsiflexion during push-off and effectively offloading the painful joint. This represents the most effective non-operative intervention. [8]

"Cartiva Caution": Synthetic cartilage implants (polyvinyl alcohol hydrogel) were introduced with promising early results but demonstrate concerning mid-term failure rates (15-25% at 5 years) due to subsidence, synovitis, and persistent pain, often necessitating complex revision arthrodesis. [9]

"Grind Test Sensitivity": The grind test (axial compression with rotation) is highly sensitive (85-90%) for intra-articular pathology and reliably distinguishes hallux rigidus from extra-articular causes of pain (sesamoiditis, metatarsalgia). [10]

---

2. Epidemiology

Prevalence and Incidence

Hallux rigidus affects approximately 2.5% of adults over 50 years of age, making it the most common arthritic condition of the foot. [1] Population studies demonstrate a bimodal age distribution with a minor peak in the 3rd-4th decades (post-traumatic etiology) and a major peak in the 6th-7th decades (degenerative etiology). [11]

Demographics

• Age: Mean age at presentation: 50-60 years for symptomatic disease requiring intervention
• Gender: Female predominance with F:M ratio of approximately 2:1 [1]
• Bilateral involvement: 80% of cases eventually develop bilateral disease, though often asymmetric in severity [2]
• Athletic populations: Higher prevalence in dancers, runners, and athletes with repetitive hyperextension loading (turf toe mechanism) [12]

Etiology and Risk Factors

Primary (Idiopathic) – 70-80% of cases:

• Anatomical variants: Long first metatarsal (metatarsus primus elevatus), flattened metatarsal head (loss of sagittal convexity), abnormal metatarsal inclination angle
• Genetic predisposition: Family history present in 40-60% of cases, suggesting hereditary structural factors [11]
• Biomechanical overload: Excessive pronation, pes planus deformity, equinus contracture

Secondary (Traumatic/Metabolic) – 20-30% of cases:

• Post-traumatic: Prior intra-articular fracture, chronic turf toe injury (repetitive hyperextension sprains), osteochondral lesions
• Inflammatory arthropathy: Gout (chronic tophaceous deposition causing secondary OA), rheumatoid arthritis, seronegative spondyloarthropathies
• Metabolic: Ochronosis (alkaptonuria), hemochromatosis
• Iatrogenic: Over-resection during hallux valgus correction (iatrogenic hallux rigidus)

Natural History

Without treatment, hallux rigidus demonstrates progressive deterioration over 5-10 years, with gradual transition from mechanical dorsal impingement pain (early stage) to global arthritis with rest pain (end-stage). [13] Conservative management provides symptomatic relief but does not alter disease progression. Approximately 60-70% of patients with moderate-to-severe symptoms eventually require surgical intervention. [4]

---

3. Pathophysiology

Functional Anatomy of the First MTP Joint

The first MTP joint is a complex articulation essential for normal gait biomechanics:

Osseous anatomy:

• Metatarsal head: Bicondylar with dorsal, plantar, and lateral articular facets
• Proximal phalanx base: Concave articular surface with ~15° dorsal inclination
• Sesamoid complex: Two sesamoid bones (tibial and fibular) embedded in the flexor hallucis brevis tendons, articulating with plantar grooves on the metatarsal head

Soft tissue stabilizers:

• Plantar plate: Thick fibrocartilaginous structure providing plantar stability
• Collateral ligaments: Medial and lateral stabilizers (tighten in dorsiflexion, relax in plantarflexion)
• Joint capsule: Dorsal capsule is thin and commonly develops synovitis; plantar capsule is reinforced by sesamoid-phalangeal ligaments

Biomechanics: The 1st MTP joint is not a simple hinge but functions as a cam mechanism with both rolling and gliding motion:

• Normal ROM: 65-75° dorsiflexion, 15-25° plantarflexion
• Gait requirements: Terminal stance (toe-off) requires 65° dorsiflexion to prevent compensatory gait alterations
• Weight transmission: Bears 40-60% of body weight during push-off [7]

Pathogenesis of Hallux Rigidus

Stage 1: Cartilage degeneration

• Repetitive microtrauma and mechanical overload lead to progressive articular cartilage breakdown
• Synovial inflammation develops, causing joint effusion and capsular thickening
• Early subchondral bone changes (sclerosis, cyst formation)

Stage 2: Dorsal osteophyte formation

• Reactive bone formation occurs preferentially at the dorsal and dorsolateral margins of the metatarsal head
• The dorsal osteophyte creates a mechanical "buttress" or "doorstop" that blocks terminal dorsiflexion
• Continued dorsiflexion attempts result in impingement pain and progressive synovitis

Stage 3: Global joint destruction

• Progressive cartilage loss leads to bone-on-bone articulation
• Diffuse osteophyte formation (circumferential rim)
• Joint space collapse with subchondral sclerosis and cyst formation
• Development of rest pain and pain throughout the arc of motion (not just terminal dorsiflexion)

Gait adaptation: Patients develop compensatory gait patterns to avoid painful dorsiflexion:

• Lateral foot roll-off (supination during toe-off)
• Shortened stride length
• Increased loading on lesser metatarsals (transfer metatarsalgia)
• Altered ankle and knee kinematics (potential for proximal joint pathology)

Classification Systems

Coughlin and Shurnas Modified Classification (Most widely used): [14]

DF = Dorsiflexion; JSN = Joint Space Narrowing; MT = Metatarsal

Hattrup and Johnson Classification (Simpler, 3-grade system):

• Grade 1: Mild changes, dorsal osteophyte, preserved joint space
• Grade 2: Moderate changes, joint narrowing, osteophyte formation, subchondral sclerosis
• Grade 3: Severe changes, marked joint space loss, extensive osteophytes, loose bodies

The Coughlin classification is preferred in contemporary practice as it better guides treatment selection and provides superior prognostic stratification. [14]

---

4. Clinical Presentation

Symptom Profile

Primary complaint: Pain

• Mechanical pain: Sharp, localized pain at the 1st MTP joint during terminal stance (push-off phase of gait)
• Character: "Jamming" or "catching" sensation with attempted dorsiflexion
• Timing: Worse with walking, running, stair climbing; relieved by rest
• Progression: Early disease—pain only with extreme dorsiflexion; late disease—pain throughout ROM and at rest

Stiffness

• Progressive loss of dorsiflexion: "I can't bend my toe up"
• Difficulty with incline walking, squatting, or kneeling (activities requiring great toe dorsiflexion)
• Sensation of "tightness" or "locking"

Swelling and deformity

• Dorsal prominence: "Bump on top of my toe" (dorsal osteophyte)
• Reactive synovitis causing joint swelling and fullness
• Unlike hallux valgus, the toe typically remains straight (no medial deviation)

Secondary symptoms

• Transfer metatarsalgia: Pain under 2nd/3rd metatarsal heads from altered gait mechanics
• Nail dystrophy: From chronic pressure in tight shoe toe box
• Callus formation: Plantar medial hallux or under lesser metatarsal heads

Functional limitations

• Difficulty with athletic activities (running, jumping, dancing)
• Problems with shoe wear (especially dress shoes, heels)
• Altered gait pattern (limping, shortened stride)

Physical Examination

Inspection (standing and non-weight-bearing)

• Alignment: Assess for hallux valgus deformity (usually minimal in hallux rigidus)
• Dorsal prominence: Visible and palpable dorsal exostosis (dorsal "bunion")
• Swelling: Joint effusion, synovial thickening
• Skin: Erythema (suggests inflammation), ulceration (red flag for infection)
• Calluses: Plantar medial hallux, lateral hallux, or transfer lesions under lesser metatarsals

Palpation

• Point tenderness: Dorsal 1st MTP joint, directly over osteophyte
• Synovitis: Palpable thickening of joint capsule
• Sesamoid tenderness: Suggests concurrent sesamoiditis (load the sesamoids with MTP plantarflexion)

Range of Motion Assessment (Critical examination component)

• Passive dorsiflexion: Measured with knee extended and subtalar joint in neutral
  • Normal: 65-75° (required for normal gait)
  • Grade 1: 40-60°
  • Grade 2: 10-40°
  • Grade 3-4: less than 10°
• Passive plantarflexion: Typically preserved until late-stage disease
• Pain arc: Note if pain occurs at end-range only (dorsal impingement) or throughout ROM (global arthritis)

Special Tests

Grind Test (Sensitivity 85-90% for intra-articular pathology): [10]

• Technique: Apply axial compression to hallux while rotating the proximal phalanx on the metatarsal head
• Positive: Pain, crepitus, or grinding sensation indicates articular cartilage damage

Passive Dorsiflexion Test

• Technique: Maximally dorsiflex the hallux and palpate for dorsal impingement
• Positive: Reproduction of pain indicates dorsal osteophyte impingement (predicts cheilectomy success)

Windlass Test (Assesses plantar fascia contribution)

• Technique: Dorsiflex hallux while palpating plantar fascia
• If pain originates from plantar fascia rather than joint, consider alternate diagnosis

Gait Assessment

• Observe for:
  • Shortened stride length
  • Early heel-off on affected side (avoiding terminal stance dorsiflexion)
  • Lateral roll-off (supinated foot position during push-off)
  • Antalgic gait pattern

Neurological Examination

• Assess sensation over dorsal and plantar hallux (excludes neuropathy)
• Check for diabetic neuropathy in at-risk patients (monofilament testing)

Vascular Examination

• Palpate dorsalis pedis and posterior tibial pulses
• Assess for signs of peripheral arterial disease (critical before surgical planning)

Differential Diagnosis

---

5. Investigations

Imaging

Radiographs (First-line, Diagnostic)

Standard views (weight-bearing essential):

Anteroposterior (AP) view:

• Joint space narrowing (often appears deceptively preserved)
• Medial and lateral osteophytes
• Sesamoid hypertrophy or degeneration
• Metatarsal length assessment (long 1st MT associated with hallux rigidus)

Lateral view (Most important for grading):

• Dorsal osteophyte ("dorsal flag sign")—pathognomonic finding
• Accurate assessment of joint space narrowing
• Metatarsal declination angle
• Dorsal subluxation of proximal phalanx

Oblique view:

• Sesamoid articulation assessment
• Lateral joint space evaluation

Radiographic grading correlates with Coughlin classification:

• Grade 0-1: Dorsal osteophyte, normal/minimal joint space narrowing
• Grade 2: Moderate joint space narrowing (less than 50%), flattening of metatarsal head, subchondral sclerosis
• Grade 3-4: Severe joint space narrowing (> 50%), extensive osteophytes, subchondral cysts, sclerosis

Advanced Imaging (Selective indications)

MRI:

• Indications:
  • Young patient with atypical presentation (exclude osteochondral lesion, AVN)
  • Suspected sesamoid pathology (osteonecrosis, fracture, chondromalacia)
  • Pre-operative planning for complex reconstruction
• Findings:
  • Cartilage mapping (quantify remaining articular cartilage)
  • Bone marrow edema (indicates active disease)
  • Synovitis severity
  • FHL tendon assessment
• Limitation: Expensive, not required for routine diagnosis

CT Scan:

• Indications:
  • Pre-operative planning for complex deformity correction
  • Assessment of subchondral cysts or loose bodies
  • Post-traumatic evaluation
• Advantage: Superior bony detail for surgical planning

Ultrasound:

• Limited role; can assess joint effusion, synovitis
• Dynamic assessment of impingement

Laboratory Investigations

Not routinely required for primary hallux rigidus

Indicated when considering inflammatory/crystalline arthropathy:

• Serum uric acid: If suspecting gout (typically > 6.8 mg/dL)
• ESR/CRP: Elevated in inflammatory arthritis or infection
• Rheumatoid factor, Anti-CCP: If suspecting rheumatoid arthritis
• Joint aspiration and synovial fluid analysis:
  • Indications: Acute red hot joint (rule out septic arthritis vs gout)
  • Analysis: Cell count, Gram stain, culture, crystal analysis
  • Findings:
    • Septic: WBC > 50,000, positive culture
    • Gout: Negative birefringent crystals (monosodium urate)
    • OA: WBC less than 2,000, no crystals

---

6. Management

Treatment Algorithm

                HALLUX RIGIDUS
                      ↓
            CLINICAL + RADIOGRAPHIC
                  EVALUATION
                      ↓
        ┌─────────────┴─────────────┐
    GRADE 1-2                   GRADE 3-4
  (Early Disease)             (Advanced Disease)
        ↓                            ↓
   CONSERVATIVE                 CONSERVATIVE
    MANAGEMENT                   MANAGEMENT
        ↓                            ↓
  - Shoe modification           - Trial if patient
  - Orthotics (Morton's)          wishes to defer
  - Activity modification         surgery
  - NSAIDs                         ↓
  - Corticosteroid injection    SURGICAL (Definitive)
        ↓                            ↓
   ADEQUATE RELIEF?              ARTHRODESIS
    Yes → Continue              (Gold Standard)
    No → SURGICAL                   ↓
        ↓                       Position:
   CHEILECTOMY                  - DF: 10-15°
 (Remove dorsal 30%)            - Valgus: 10-15°
        ↓                       - Neutral rotation
   90% satisfaction                 ↓
   at 5 years [15]             95% satisfaction [5]
        ↓
   (Eventual progression
   to arthrodesis in
   30-40% by 10 years)

Alternative for Grade 3-4:
   ARTHROPLASTY
   (Implant/Interposition)
        ↓
   Higher failure rate
   Consider in: Low-demand,
   bilateral disease,
   ipsilateral ankle arthrodesis

---

7. Conservative Management

Conservative treatment does not alter disease progression but provides symptomatic relief and may delay surgical intervention by 2-5 years in 40-60% of patients. [8]

Non-Pharmacological Interventions

1. Shoe Modification (First-line intervention)

• Wide toe box: Accommodates dorsal prominence, reduces pressure over osteophyte
• Stiff-soled shoes: Decreases 1st MTP joint motion during gait
• Rocker-bottom sole: Facilitates roll-through, minimizing MTP dorsiflexion requirement
• Low heel height: Reduces dorsiflexion demand (conversely, high heels increase dorsiflexion stress)
• Stretching toe box: Cobbler modification to create room for dorsal exostosis

2. Orthotic Devices (Most effective conservative intervention)

• Morton's extension orthotic:
  • Rigid carbon-fiber or steel plate extending under 1st ray and hallux
  • Mechanism: Prevents 1st MTP joint motion by creating external splint
  • Effectiveness: 60-70% report good-to-excellent relief at 1 year [8]
  • Limitation: Requires stiff-soled footwear; not compatible with flexible shoes
• Custom foot orthoses:
  • First ray cutout to offload 1st MTP joint
  • Metatarsal pad to redistribute pressure to lesser metatarsals
• Toe spacers: Maintain hallux alignment, prevent medial drift

3. Activity Modification

• Avoid activities requiring repetitive push-off (running, jumping, incline walking)
• Substitute low-impact exercise (cycling, swimming, elliptical)
• Kinetic chain training to minimize compensatory gait patterns

4. Physical Therapy

• Limited role (motion exercises may exacerbate pain)
• Gait training to optimize mechanics
• Strengthening of intrinsic foot musculature
• Calf stretching if equinus contracture present

Pharmacological Interventions

1. Oral Medications

• NSAIDs:
  • First-line for pain and inflammation
  • Typical regimen: Ibuprofen 400-600 mg TID or naproxen 500 mg BID
  • Duration: 2-4 week trial; avoid chronic use
  • Precautions: GI, renal, cardiovascular risks
• Acetaminophen: Alternative for patients with NSAID contraindications
• Topical NSAIDs: Diclofenac gel—lower systemic absorption, fewer side effects

2. Intra-articular Corticosteroid Injection

• Indication: Refractory pain despite conservative measures, patient seeking to delay surgery
• Technique:
  • Dorsomedial or dorsolateral approach (avoid plantar neurovascular structures)
  • Corticosteroid: Methylprednisolone 20-40 mg or triamcinone 20 mg
  • Often mixed with local anesthetic (lidocaine 1%)
• Effectiveness:
  • 60-70% experience pain relief
  • Duration: Typically 3-6 months (range 1-12 months) [16]
  • Diminishing returns with repeated injections
• Risks: Cartilage damage with repeated use, infection (rare less than 0.1%), plantar plate rupture (if injected plantarly)
• Recommendation: Limit to 2-3 injections total

3. Viscosupplementation (Hyaluronic Acid)

• Evidence: Limited and inconsistent; not routinely recommended
• Some studies show modest short-term improvement but inferior to corticosteroid
• Not FDA-approved for 1st MTP joint

Expected Outcomes of Conservative Management

• 40-60% of patients with mild-to-moderate disease (Grades 1-2) achieve adequate symptom control to avoid or defer surgery for 2-5 years [8]
• Conservative measures are temporizing; they do not reverse joint degeneration
• Progression to surgical intervention is common in moderate-to-severe disease

---

8. Surgical Management

Surgical intervention is indicated when conservative management fails to provide adequate pain relief or functional restoration. Procedure selection is primarily determined by radiographic grade and remaining joint function.

1. Cheilectomy (Joint-Preserving Procedure)

Indications:

• Grades 1-2 hallux rigidus (preserved joint space, less than 50% cartilage loss)
• Dominant symptom: Dorsal impingement pain with attempted dorsiflexion
• Younger, active patients desiring motion preservation
• Failed conservative management

Surgical Technique:

• Approach: Dorsomedial incision over 1st MTP joint
• Exposure: Capsulotomy (inverted L or linear), identify dorsal osteophyte
• Resection:
  • Remove dorsal osteophyte en bloc
  • Resect dorsal 25-30% of metatarsal head using oscillating saw
  • Remove proliferative synovium
  • Smooth edges with rongeur/burr
  • Inspect articular cartilage (if > 50% loss, consider alternative procedure)
• Closure: Repair capsule, close skin

Modifications:

• Moberg osteotomy (dorsal closing-wedge osteotomy of proximal phalanx): Added to decompress joint and increase functional dorsiflexion
• Valenti procedure: Cheilectomy + plantar release for severe restriction

Outcomes:

• Success rate: 85-97% good-to-excellent results at 5 years for appropriately selected patients (Grades 1-2) [15]
• ROM improvement: Average gain of 20-25° dorsiflexion
• Pain relief: 90% achieve significant pain reduction
• Durability: 70% maintain benefit at 10 years; 30-40% progress to arthrodesis within 10 years [17]

Complications:

• Progression of arthritis (30-40% by 10 years)
• Inadequate resection (residual impingement)
• Over-resection (transfer metatarsalgia, instability)
• Recurrent synovitis
• Infection (less than 2%)

Predictors of failure:

• Grade 3-4 disease (> 50% cartilage loss)
• Mid-range pain (not just dorsal impingement)
• Severe restriction (less than 10° dorsiflexion pre-operatively)

2. Arthrodesis (1st MTP Fusion) - Gold Standard for Advanced Disease

Indications:

• Grades 3-4 hallux rigidus (> 50% joint space loss, end-stage arthritis)
• Failed cheilectomy
• Mid-range or rest pain (not just impingement)
• High-demand patients requiring reliable long-term solution
• Inflammatory arthropathy affecting 1st MTP joint

Surgical Technique:

Approach:

• Dorsal longitudinal incision centered over 1st MTP joint
• Protect dorsomedial neurovascular bundle (medial dorsal cutaneous nerve)

Joint Preparation:

• Remove articular cartilage from metatarsal head and phalangeal base
• Cup-and-cone technique (preferred):
  • Ream metatarsal head to create convex surface
  • Ream phalangeal base to create concave surface
  • Maximizes contact area, enhances stability
• Alternative: Flat-cut with planar resection
• Debride to bleeding subchondral bone

Positioning (Critical for optimal outcome):

• Dorsiflexion: 10-15° relative to weight-bearing surface (floor)
  • Too much: Painful tip pressure, shoe wear difficulty
  • Too little: Inadequate toe-off clearance, stubbing
• Valgus: 10-15° (hallux should align with or slightly lateral to second toe)
  • Too much valgus: Risk of 1st-2nd toe crossover
  • Too little (varus): Risk of medial pressure, IPJ arthritis
• Rotation: Neutral (toenail faces upward with foot flat)
  • Assess with knee flexed to 90° and ankle neutral

Fixation Options:

• Dorsal plate + compression screw (most rigid construct, preferred):
  • Low-profile dorsal locking plate
  • Lag screw for interfragmentary compression
  • Union rate: 95-98%
• Crossed lag screws (traditional):
  • Two 3.5mm or 4.0mm lag screws in oblique configuration
  • Union rate: 90-95%
  • Less rigid than plate construct
• Intermedullary screw (newer technique):
  • Single retrograde intramedullary compression screw
  • Minimal dissection, low profile
  • Emerging data suggest comparable union rates

Post-operative Protocol:

• Non-weight-bearing in CAM boot: 2 weeks
• Protected weight-bearing in stiff-soled shoe: 4-6 weeks
• Radiographic union assessment: 6-8 weeks
• Return to regular shoes: 8-12 weeks
• Full activity: 3-4 months

Outcomes:

• Union rate: 90-98% (varies by fixation method) [5,18]
• Patient satisfaction: 90-95% good-to-excellent results
• Pain relief: 95% achieve complete or near-complete pain resolution
• Functional outcomes:
  • Normal walking, jogging, hiking permitted
  • Limitations: High heels (> 2 inches), competitive sprinting, ballet
• Durability: Excellent long-term results; 85-90% satisfaction maintained at 10+ years [6]

Complications:

• Non-union: 5-10% (higher with screw-only fixation)
  • Risk factors: Smoking, diabetes, NSAIDs, poor bone quality
  • Treatment: Revision with bone graft ± plate fixation
• Malposition: 5-10%
  • Too much DF: Painful tip, ulceration
  • Insufficient DF: Stubbing, transfer metatarsalgia
  • Excessive valgus: IPJ arthritis, 2nd toe crossover
  • Treatment: Revision osteotomy (technically demanding)
• Transfer metatarsalgia: 10-15%
  • Mechanism: Altered weight distribution to lesser metatarsals
  • Prevention: Proper sagittal plane positioning
  • Treatment: Orthotic offloading, rarely metatarsal osteotomy
• IP joint arthritis: 15-20% long-term (compensatory hypermobility)
• Hardware irritation: 5-10% (more common with prominent screw heads)
• Infection: 2-3%
• Nerve injury: Medial dorsal cutaneous nerve (numbness dorsomedial hallux)

3. Arthroplasty (Joint Replacement/Resurfacing)

Types:

A. Hemiarthroplasty

• Metallic resurfacing of metatarsal head (HemiCAP, ToeFit)
• Preserves bone stock, maintains motion

B. Total Joint Replacement

• Metatarsal and phalangeal components (silicone or metal-polyethylene)
• Historical silicone implants (Swanson) now largely abandoned due to high failure rates

C. Synthetic Cartilage Implant

• Cartiva (polyvinyl alcohol hydrogel implant replacing metatarsal head cartilage)
• FDA-approved; gained popularity in 2016-2020

D. Interposition Arthroplasty

• Keller procedure: Resection of proximal phalangeal base
• Capsule/tendon interposition to prevent bone-on-bone contact

Indications: (Controversial; limited role in current practice)

• Low-demand elderly patients
• Bilateral disease with contralateral ankle arthrodesis (avoid bilateral hindfoot/ankle stiffness)
• Patient refusal of fusion
• Inflammatory arthropathy with polyarticular involvement

Outcomes:

• Success rates: Highly variable (60-85% satisfaction at 5 years)
• Failure rates: 15-25% at 5 years for Cartiva [9]; higher for silicone implants
• Complications:
  • Subsidence (implant sinking into bone)
  • Synovitis/foreign body reaction
  • Loosening/migration
  • Persistent pain
  • Revision to arthrodesis often challenging due to bone loss

Current Consensus: First MTP arthrodesis remains the gold standard for Grade 3-4 disease. Arthroplasty should be reserved for highly selected cases. Cartiva and metallic hemiarthroplasty show promise but require longer-term follow-up. [9,18]

4. Keller Procedure (Resection Arthroplasty)

Technique: Resection of proximal 1/3 of proximal phalanx base

Indications: (Very limited in modern practice)

• Elderly, sedentary, low-demand patients
• Severe deformity precluding other options
• Salvage for failed implant arthroplasty

Outcomes:

• Pain relief in 70-80%
• Major drawbacks:
  • Loss of push-off strength (floppy, unstable toe)
  • Cock-up deformity (dorsal subluxation)
  • Transfer metatarsalgia (up to 50%)
  • Hallux varus deformity
• Largely replaced by arthrodesis in contemporary practice

---

9. Complications and Long-Term Sequelae

Untreated Hallux Rigidus

Gait dysfunction:

• Compensatory supination during terminal stance
• Shortened stride length, reduced walking speed
• Increased loading on lateral foot and lesser metatarsals

Transfer metatarsalgia:

• 40-50% develop pain under 2nd/3rd metatarsals from altered mechanics
• Risk of stress fracture, plantar plate insufficiency

Proximal joint stress:

• Altered ankle and knee kinematics
• Theoretical risk of accelerated degeneration (limited evidence)

Functional limitation:

• Reduced walking distance, difficulty with slopes/stairs
• Athletic limitation, vocational disability (occupations requiring walking/standing)

Post-Surgical Complications

Early (less than 6 weeks):

• Wound infection (2-3%)
• Wound dehiscence (diabetics, smokers)
• Nerve injury (medial dorsal cutaneous nerve)
• Hematoma
• Deep vein thrombosis (rare)

Intermediate (6 weeks - 6 months):

• Delayed union or non-union (arthrodesis)
• Hardware failure
• Complex regional pain syndrome (rare)

Late (> 6 months):

• Malposition (arthrodesis)
• Transfer metatarsalgia
• IP joint arthritis (15-20% after fusion)
• Hardware irritation
• Recurrent arthritis (cheilectomy)

---

10. Prognosis and Outcomes

Natural History

• Progressive condition: Without treatment, 70-80% of symptomatic patients worsen over 5-10 years [13]
• Spontaneous improvement is rare
• Conservative management provides temporary relief but does not alter disease trajectory

Surgical Outcomes Summary

Predictors of Good Outcome

Cheilectomy:

• Grade 1-2 disease (preserved joint space)
• Isolated dorsal impingement (not mid-range pain)
• Pre-operative dorsiflexion > 20°

Arthrodesis:

• Proper positioning (DF 10-15°, valgus 10-15°)
• Rigid fixation (plate preferred over screws alone)
• Non-smoker, non-diabetic
• Patient acceptance of stiff toe

---

11. Evidence and Guidelines

Key Clinical Trials and Studies

Arthrodesis vs Arthroplasty: Gibson et al. (2005) conducted a randomized controlled trial comparing first MTP arthrodesis to Biomet total toe arthroplasty. At 2-year follow-up, the arthrodesis group demonstrated superior functional outcomes (AOFAS scores), lower pain scores, and significantly fewer revision procedures compared to the arthroplasty group. The study concluded that arthrodesis remains the gold standard for end-stage hallux rigidus. [5]

Cheilectomy Outcomes: Coughlin and Shurnas (2003) reported long-term outcomes of cheilectomy in 80 patients (93 feet) with mean 9.6-year follow-up. In patients with Grade 1-2 disease, 97% achieved good-to-excellent outcomes. However, progression to arthrodesis occurred in 30% of Grade 3 patients, confirming that cheilectomy should be reserved for early-stage disease with preserved joint space. [14,15]

Cartiva Synthetic Cartilage Implant: Recent multi-center studies show concerning mid-term failure rates. Baumhauer et al. (2016) reported initial FDA trial results with 94% survivorship at 2 years. However, subsequent studies demonstrate 15-25% failure rates at 5 years due to subsidence, persistent pain, and synovitis, often necessitating complex revision arthrodesis with bone grafting. [9]

Professional Society Guidelines

American Orthopaedic Foot and Ankle Society (AOFAS):

• Recommends conservative management as first-line for all grades
• Cheilectomy for Grades 1-2 with dorsal impingement
• Arthrodesis as gold standard for Grades 3-4
• Arthroplasty reserved for selected low-demand patients

National Institute for Health and Care Excellence (NICE):

• Supports stepwise treatment algorithm
• Emphasizes importance of shoe modification and orthotics
• Arthrodesis recognized as most reliable surgical option for advanced disease

---

12. Patient Education and Shared Decision-Making

Explaining the Condition (Layperson Language)

What is hallux rigidus? Your big toe joint has developed arthritis—the cartilage cushion has worn away, and a bone spur has grown on top of the joint. This spur acts like a doorstop, preventing your toe from bending upward. Every time you push off while walking, the toe tries to bend but hits this blockage, causing pain.

Why did this happen? In most cases, we don't know exactly why. Some people have foot shapes (long big toe bone, flat arch) that put extra stress on this joint over time. It's like wearing out a hinge from repeated use. In other cases, it follows an old injury to the toe.

Will it get worse? Yes, hallux rigidus is a progressive condition. Without treatment, the arthritis usually worsens over 5-10 years. However, treatments can effectively control symptoms and maintain function.

Treatment Options Explained

Non-surgical options:

• Stiff-soled shoes with carbon fiber inserts: This is like putting a splint under your toe to stop it from bending during walking. It prevents the painful motion.
• Wider shoes: Room for the bump on top of your toe
• Anti-inflammatory medication: Reduces swelling and pain
• Cortisone injection: Steroid injection into the joint provides 3-6 months of relief for many patients

When these don't work enough, surgery options include:

1. Cheilectomy ("shaving the spur") - For early-stage arthritis

• We remove the bone spur and shave down the top of the joint
• This "unblocks" the doorstop and allows the toe to bend more freely
• Pros: Preserves motion, quick recovery (8-12 weeks)
• Cons: The arthritis can continue to worsen; 30-40% eventually need fusion within 10 years
• Best for: Younger, active patients with early arthritis

2. Fusion (arthrodesis) - For advanced arthritis

• We remove the remaining damaged cartilage and fuse the bones together permanently
• The toe is positioned in a slightly bent-up position to allow normal walking
• Pros: 95% pain relief, permanent solution, excellent long-term results
• Cons: The toe will not bend (but you can still walk, jog, hike normally)
• Recovery: 12-16 weeks

Common patient questions about fusion:

• "Will I walk funny?" No. The toe is fused in a position that allows completely normal walking. You will not limp.
• "Can I run?" Yes. Most patients return to jogging and recreational running.
• "Can I wear heels?" Low heels (less than 2 inches) are fine. High heels (> 3 inches) will be uncomfortable.
• "Does the surgery hurt?" There is post-operative pain for 2-4 weeks, but once healed, 95% of patients have no pain.
• "Will the fusion break?" Very rarely. The bone heals in 95-98% of cases with modern fixation techniques.

3. Joint replacement - Limited role

• Newer options (metal caps, synthetic cartilage) aim to preserve motion
• Reality: Higher failure rates than fusion; many need revision surgery
• Best for: Older, low-demand patients or those with specific contraindications to fusion

Realistic Expectations

Conservative treatment:

• Provides good symptom relief in 40-60% of early-stage patients
• Does not stop the arthritis from progressing
• May delay need for surgery by 2-5 years

Cheilectomy:

• Excellent pain relief and motion improvement in early-stage disease
• Buys 5-10 years before possible need for fusion
• Not a permanent solution

Fusion:

• Most reliable long-term solution
• Permanent pain relief in 95% of cases
• Trade-off: Loss of toe motion for elimination of pain
• Excellent patient satisfaction (90-95%)

---

13. Special Populations

Athletes and High-Demand Patients

• Early intervention with cheilectomy may extend athletic career
• Fusion well-tolerated for most sports (running, cycling, hiking)
• Elite sprinting, ballet require intact 1st MTP motion (fusion may end career)
• Consider arthroplasty in professional athletes unwilling to accept fusion (acknowledge higher failure risk)

Diabetic Patients

• Higher surgical complication rates (infection, delayed healing)
• Assess vascular status pre-operatively (ABI, pulse exam)
• Ensure optimal glycemic control (HbA1c less than 7.5%)
• More aggressive wound care and infection prophylaxis
• Consider extended non-weight-bearing period

Patients with Concurrent Foot Pathology

• Hallux valgus + hallux rigidus: Rare severe combination; may require combined procedure or staged correction
• Ipsilateral ankle arthrodesis: Avoid 1st MTP fusion if possible (creates excessively stiff hindfoot/forefoot); consider arthroplasty
• Pes planus deformity: May require concurrent arch correction (flatfoot reconstruction)

---

14. Future Directions and Emerging Therapies

Biologic Therapies

• Platelet-rich plasma (PRP): Limited evidence; not currently recommended
• Stem cell therapy: Investigational; no high-quality RCTs
• Hyaluronic acid viscosupplementation: Mixed results; inferior to corticosteroid

Advanced Implant Technology

• Newer-generation polyurethane and ceramic implants under investigation
• Goal: Improve on high failure rates of current arthroplasty devices
• Long-term data still lacking

Arthroscopic Cheilectomy

• Minimally invasive alternative to open cheilectomy
• Potentially faster recovery, less soft tissue disruption
• Technically demanding; limited data on long-term outcomes

Cartilage Regeneration

• Microfracture, autologous chondrocyte implantation (ACI)
• Limited applicability to 1st MTP joint (high load, small surface area)
• Investigational stage only

---

15. Viva Voce and Examination Pearls

High-Yield Examination Questions

Q1: What is the optimal position for first MTP arthrodesis?

Model Answer: The position is critical for optimal functional outcome:

• Dorsiflexion: 10-15 degrees relative to the weight-bearing surface (floor), ensuring adequate toe-off clearance
• Valgus: 10-15 degrees (hallux aligned with or slightly lateral to second toe to prevent 1st-2nd interspace narrowing)
• Rotation: Neutral (toenail faces upward when foot is flat)

This is assessed intra-operatively with the knee flexed to 90 degrees and the ankle in neutral. Malposition is a major cause of patient dissatisfaction and may require revision osteotomy.

Q2: Describe the Coughlin and Shurnas classification of hallux rigidus.

Model Answer: A 5-grade system (0-4) based on clinical and radiographic findings:

• Grade 0: Dorsal osteophyte only, normal ROM, no symptoms
• Grade 1: Mild pain, dorsal osteophyte, minimal joint narrowing, DF 40-60°
• Grade 2: Moderate pain, flattening of MT head, less than 50% cartilage loss, DF 10-40°
• Grade 3: Severe pain, > 50% joint space loss, cysts/sclerosis, DF less than 10°
• Grade 4: Grade 3 features plus pain at mid-range and rest (global arthritis)

This classification guides treatment: Grades 1-2 are amenable to cheilectomy; Grades 3-4 require arthrodesis or arthroplasty.

Q3: What is a cheilectomy and what are the outcomes?

Model Answer: Cheilectomy is excision of the dorsal osteophyte and dorsal 25-30% of the metatarsal head to relieve dorsal impingement and restore dorsiflexion.

Indications: Grade 1-2 hallux rigidus with isolated dorsal impingement

Technique: Dorsal approach, remove exostosis en bloc, resect dorsal metatarsal head, synovectomy

Outcomes:

• 85-97% good-to-excellent results at 5 years in appropriately selected patients (Coughlin, 2003)
• Average gain of 20-25° dorsiflexion
• 30-40% progress to arthrodesis by 10 years due to underlying arthritis progression

Failure predictors: Grade 3-4 disease, mid-range pain, severe pre-operative restriction

Q4: Compare arthrodesis vs arthroplasty for Grade 3-4 hallux rigidus.

Model Answer:

Arthrodesis (Gold standard):

• Pros: 90-95% satisfaction, permanent pain relief, excellent durability (85-90% at 10y), low revision rate (5-10%)
• Cons: Loss of MTP motion, limits high heels and elite sprinting, risk of IP joint arthritis (15-20%), transfer metatarsalgia (10-15%)

Arthroplasty (Implant/resurfacing):

• Pros: Preserves motion, bilateral procedure feasible, potentially faster recovery
• Cons: Higher failure rate (15-25% at 5y for Cartiva), subsidence, synovitis, persistent pain, revision to fusion often complicated by bone loss

RCT Evidence: Gibson et al. (2005) showed arthrodesis superior to arthroplasty in functional outcomes and revision rates.

Recommendation: Arthrodesis for most patients with Grade 3-4 disease. Arthroplasty reserved for highly selected low-demand patients or those with bilateral disease and ipsilateral ankle fusion.

Q5: What is the Keller procedure and what is its role?

Model Answer: Keller procedure is resection arthroplasty involving excision of the proximal 1/3 to 1/2 of the proximal phalanx base.

Historical use: Common in mid-20th century for hallux rigidus and hallux valgus

Outcomes:

• Pain relief in 70-80%
• Major complications: Floppy, unstable toe (loss of push-off strength), cock-up deformity (40%), transfer metatarsalgia (50%), hallux varus

Current role: Very limited; reserved for elderly, sedentary patients with severe deformity or as salvage for failed arthroplasty. Largely replaced by arthrodesis in modern practice.

Q6: Describe the radiographic features of hallux rigidus.

Model Answer:

AP view:

• Joint space narrowing (often underestimated)
• Medial and lateral osteophytes
• Sesamoid hypertrophy or degeneration
• Squaring of metatarsal head

Lateral view (most important):

• Dorsal osteophyte ("dorsal flag sign")—pathognomonic
• Accurate assessment of joint space narrowing
• Dorsal subluxation of proximal phalanx in advanced cases

Grading correlates:

• Grade 1-2: Dorsal osteophyte, preserved or minimally narrowed joint space
• Grade 3-4: Severe joint space loss (> 50%), extensive osteophytes, subchondral sclerosis and cysts

Advanced imaging: MRI rarely needed; useful for excluding osteochondral lesions or assessing sesamoid pathology in atypical cases.

---

16. Key Takeaways for Clinical Practice

1. Hallux rigidus is the most common arthritic condition of the foot, affecting 2.5% of adults over 50.

2. Dorsal osteophyte formation creates mechanical impingement, blocking dorsiflexion and causing characteristic push-off pain.

3. Classification drives treatment: Coughlin Grade 1-2 (preserved joint space) → consider cheilectomy; Grade 3-4 (end-stage) → arthrodesis.

4. Conservative management is first-line for all grades: Stiff-soled shoes, Morton's extension orthotic, NSAIDs, corticosteroid injection.

5. Cheilectomy provides excellent short-to-intermediate relief in early disease (85-97% satisfaction at 5 years) but 30-40% eventually progress to fusion.

6. Arthrodesis is the gold standard for Grade 3-4 disease: 90-95% satisfaction, permanent pain relief, excellent durability. Proper positioning is critical (DF 10-15°, valgus 10-15°).

7. Arthroplasty has a limited role: Higher failure rates than fusion; consider only in highly selected patients (low-demand, bilateral disease, ipsilateral ankle fusion).

8. Patient education is essential: Address fusion misconceptions—patients can walk, jog, and hike normally; limitations confined to high heels and elite sprinting.

---

17. References

1. Menz HB, Roddy E, Thomas E, Croft PR. Impact of hallux valgus severity on general and foot-specific health-related quality of life. Arthritis Care Res (Hoboken). 2011;63(3):396-404. PMID: 21080349

2. Gould N, Schneider W, Ashikaga T. Epidemiological survey of foot problems in the continental United States: 1978-1979. Foot Ankle. 1980;1(1):8-10. PMID: 7319437

3. Shereff MJ, Baumhauer JF. Hallux rigidus and osteoarthrosis of the first metatarsophalangeal joint. J Bone Joint Surg Am. 1998;80(6):898-908. PMID: 9655108

4. Beeson P, Phillips C, Corr S, Ribbans W. Classification systems for hallux rigidus: a review of the literature. Foot Ankle Int. 2008;29(4):407-414. PMID: 18442456

5. Gibson JN, Thomson CE. Arthrodesis or total replacement arthroplasty for hallux rigidus: a randomized controlled trial. Foot Ankle Int. 2005;26(9):680-690. PMID: 16174497

6. Coughlin MJ, Shurnas PS. Hallux rigidus: demographics, etiology, and radiographic assessment. Foot Ankle Int. 2003;24(10):731-743. PMID: 14587987

7. DeFrino PF, Brodsky JW, Pollo FE, Crenshaw SJ, Beischer AD. First metatarsophalangeal arthrodesis: a clinical, pedobarographic and gait analysis study. Foot Ankle Int. 2002;23(6):496-502. PMID: 12095117

8. Grady JF, Axe TM, Zager EJ, Sheldon LA. A retrospective analysis of 772 patients with hallux limitus. J Am Podiatr Med Assoc. 2002;92(2):102-108. PMID: 11847262

9. Baumhauer JF, Singh D, Glazebrook M, et al. Prospective, randomized, multi-centered clinical trial assessing safety and efficacy of a synthetic cartilage implant versus first metatarsophalangeal arthrodesis in advanced hallux rigidus. Foot Ankle Int. 2016;37(5):457-469. PMID: 26762581

10. Nawoczenski DA, Baumhauer JF, Umberger BR. Relationship between clinical measurements and motion of the first metatarsophalangeal joint during gait. J Bone Joint Surg Am. 1999;81(3):370-376. PMID: 10199275

11. Camasta CA. Hallux limitus and hallux rigidus. Clinical examination, radiographic findings, and natural history. Clin Podiatr Med Surg. 1996;13(3):423-448. PMID: 8829031

12. McNeil DS, Baumhauer JF, Glazebrook MA. Evidence-based analysis of the efficacy for operative treatment of hallux rigidus. Foot Ankle Int. 2013;34(1):15-32. PMID: 23386757

13. Hattrup SJ, Johnson KA. Subjective results of hallux rigidus following treatment with cheilectomy. Clin Orthop Relat Res. 1988;(226):182-191. PMID: 3335093

14. Coughlin MJ, Shurnas PS. Hallux rigidus. Grading and long-term results of operative treatment. J Bone Joint Surg Am. 2003;85(11):2072-2088. PMID: 14630834

15. Coughlin MJ, Shurnas PS. Soft-tissue arthroplasty for hallux rigidus. Foot Ankle Int. 2003;24(9):661-672. PMID: 14524514

16. Solan MC, Calder JD, Bendall SP. Manipulation and injection for hallux rigidus. Is it worthwhile? J Bone Joint Surg Br. 2001;83(5):706-708. PMID: 11476309

17. Easley ME, Davis WH, Anderson RB. Intermediate to long-term follow-up of medial-approach dorsal cheilectomy for hallux rigidus. Foot Ankle Int. 1999;20(3):147-152. PMID: 10195291

18. Roukis TS. Outcomes after cheilectomy with phalangeal dorsiflexory osteotomy for hallux rigidus: a systematic review. J Foot Ankle Surg. 2010;49(5):479-487. PMID: 20797583

---

18. Related Topics for Further Study

• Hallux Valgus: Understanding the differential diagnosis and distinguishing features
• Gout and Podagra: Acute inflammatory arthropathy of the 1st MTP joint
• Sesamoiditis and Sesamoid Disorders: Plantar 1st MTP pain syndromes
• Turf Toe: Acute hyperextension injury to the 1st MTP joint
• Transfer Metatarsalgia: Secondary overload of lesser metatarsals
• First MTP Joint Anatomy and Biomechanics: Foundational understanding
• Principles of Arthrodesis: General surgical principles applicable to multiple joints
• Foot and Ankle Arthroplasty: Comparative approaches to joint preservation vs fusion

---

(End of Enhanced Topic - Hallux Rigidus)